AC
Adaptive Capital Partners is a Singapore-based, early-stage venture capital firm established in 2022. It invests in high-conviction, technology-driven companies with a focus on HealthTech, Life Sciences, and deep tech across Southeast Asia.
They made 3 investments in the last 12 months. Their most common stage is series-a (71% of deals). Average disclosed round size is $10.7M (across 5 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
JP
Jack Perkins
Managing Director
DL
David Liow
Partner
KY
Kar Yew Lee
Investment Associate
AN
Anusha Nair Sredharan
Senior Investment Manager
GY
Guan Yen Liew
Venture Capital
AG
Aaron Gill
VC fund
RP
Rou Phuah
Investments
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| RRespiree Pte Ltd | Series A | — | Feb 2026 |
| RRespiree Pte Ltd | Series A | $11.6M | Jul 2025 |
| RRespiree | Series A | $11.6M | Jul 2025 |
 Biorithm | Series A | $3.5M | Dec 2023 |
 Aktivolabs | Series A | $10M | Jan 2022 |
| AAOA | Unknown | $17M | — |
 Oxford Quantum Circuits | Series C | — | — |
Top Co-Investors
SEEDS Capital5 shared
We Venture Capital3 shared
ClavystBio3 shared
XYZ Venture Capital1 shared
Labcorp1 shared
Astia1 shared
Joyance Partners1 shared
Y Combinator1 shared
RH Capital1 shared
The Helm1 shared
Good Growth Capital1 shared
VU Venture Partners1 shared
LongeVC1 shared
Oxford Capital1 shared
Pentland Group1 shared
British Business Bank1 shared
Oxford Science Enterprises1 shared
Alpha Edison1 shared
Fulcrum Equity Partners1 shared
Chevron Technology Ventures1 shared
Last updated: 8 September 2026